Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 5,575 GBp
Change Today -35.00 / -0.62%
Volume 432.4K
SHP On Other Exchanges
Symbol
Exchange
SHP is not on other exchanges.
As of 8:16 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitleKey Developments
David Kappler 44 RelationshipsDeputy Chairman, Senior Independent Non-executive Director, Chairman of Nomination Committee and Member of Audit, Compliance & Risk CommitteeShire Pharmaceuticals Group plc Restates its Financial Results for the Year 2003
08/3/04
Dominic Blakemore 18 RelationshipsNon-Executive Director and Chairman of Audit, Compliance & Risk Committee 
Steven Gillis M.D., Ph.D. 148 RelationshipsIndependent Non-Executive Director, Member of Remuneration Committee, Member of Science & Technology Committee and Member of Audit, Compliance & Risk Committee 

Compensation Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitle
William Burns BA 48 RelationshipsIndependent Non-Executive Director, Member of Nomination Committee, Member of Remuneration Committee and Member of Science & Technology Committee
Steven Gillis M.D., Ph.D. 148 RelationshipsIndependent Non-Executive Director, Member of Remuneration Committee, Member of Science & Technology Committee and Member of Audit, Compliance & Risk Committee
Anne Minto OBE 29 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee and Member of Nomination Committee
SHP Compensation vs. Industry
1.3M
450.1K
Chief Executive Officer
Share price activity for SHIRE PLC (SHP)
52 Week Price Performance
SHP
Industry Average

Nominating Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitleKey Developments
Susan Saltzbart Kilsby 47 RelationshipsNon-Executive Chairman and Member of Nomination CommitteeShire plc Appoints Jeff Poulton as Chief Financial Officer, Member of the Executive Committee and to Board of Directors
04/30/15
David Kappler 44 RelationshipsDeputy Chairman, Senior Independent Non-executive Director, Chairman of Nomination Committee and Member of Audit, Compliance & Risk CommitteeShire plc Announces David Stout to Step Down from the Board and the Committees, Effective from April 28, 2015
02/12/15
Anne Minto OBE 29 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee and Member of Nomination CommitteeShire plc Announces Board Changes
01/23/14
William Burns BA 48 RelationshipsIndependent Non-Executive Director, Member of Nomination Committee, Member of Remuneration Committee and Member of Science & Technology CommitteeShire plc Appoints Dominic Blakemore as Non-Executive Director and Member, Effect from January 1, 2014
10/23/13

Executive Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitle
Michael Cola 73 RelationshipsFormer Executive Officer
Barbara Deptula 7 RelationshipsFormer Chief Corporate Development Officer, Executive Vice President and Member of Management Committee
Anita Graham 0 RelationshipsFormer Chief Administrative Officer, Executive Vice President of Corporate Business Services and Member of Management Committee
John Lee 0 RelationshipsFormer Executive Vice President of Global Supply Chain & Quality
Jeffrey Leiden M.D., Ph.D. 138 RelationshipsFormer Vice Chairman, Chairman of Science & Technology Committee, Member of Nomination Committee and Member of Remuneration Committee
David Pendergast Ph.D. 0 RelationshipsFormer Executive Vice President of human genetic therapies
Joseph Rus 8 RelationshipsFormer Executive Vice President of Market Alliance & New Product Development and Member of Management Committee
Eliseo Salinas M.D., M.Sc. 0 RelationshipsFormer Chief Scientific Officer, Executive Vice President of Global Research & Development and Member of Management Committee
Management Effectiveness Relative to the Industry
Return on Equity
2.4x
Return on Assets
1.7x
Return on Total Capital
1.6x
TEV/Total Revenue(LTM)
1.6x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHP:LN 5,575.00 GBp -35.00

SHP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CSL Ltd A$93.05 AUD -0.29
Eisai Co Ltd ¥8,030 JPY +58.00
Hospira Inc $88.42 USD 0.00
Mylan NV $73.32 USD +0.69
UCB SA €67.40 EUR +1.30
View Industry Companies
 

Industry Analysis

SHP

Industry Average

Valuation SHP Industry Range
Price/Earnings 14.8x
Price/Sales 8.2x
Price/Book 5.7x
Price/Cash Flow 14.2x
TEV/Sales 8.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.